Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)
- Author
- Flor Verghote (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Ben Vanneste (UGent) , Sara Junius, Nick Liefhooghe, Leen Noé, Gert De Meerleer, Piet Ost (UGent) and Valerie Fonteyne (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01J8FZK1NWZ8S9KP0PKJNA7X7T
- MLA
- Verghote, Flor, et al. “Adjuvant EBRT for Muscle-Invasive Bladder Cancer : Phase 2 Trial Secondary Analysis (NCT02397434).” RADIOTHERAPY AND ONCOLOGY, vol. 194, no. Supplement 1, 2024, pp. S2308–11, doi:10.1016/s0167-8140(24)00952-6.
- APA
- Verghote, F., Dirix, P., Van Praet, C., Berghen, C., Vanneste, B., Junius, S., … Fonteyne, V. (2024). Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434). RADIOTHERAPY AND ONCOLOGY, 194(Supplement 1), S2308–S2311. https://doi.org/10.1016/s0167-8140(24)00952-6
- Chicago author-date
- Verghote, Flor, Piet Dirix, Charles Van Praet, Charlien Berghen, Ben Vanneste, Sara Junius, Nick Liefhooghe, et al. 2024. “Adjuvant EBRT for Muscle-Invasive Bladder Cancer : Phase 2 Trial Secondary Analysis (NCT02397434).” In RADIOTHERAPY AND ONCOLOGY, 194:S2308–11. https://doi.org/10.1016/s0167-8140(24)00952-6.
- Chicago author-date (all authors)
- Verghote, Flor, Piet Dirix, Charles Van Praet, Charlien Berghen, Ben Vanneste, Sara Junius, Nick Liefhooghe, Leen Noé, Gert De Meerleer, Piet Ost, and Valerie Fonteyne. 2024. “Adjuvant EBRT for Muscle-Invasive Bladder Cancer : Phase 2 Trial Secondary Analysis (NCT02397434).” In RADIOTHERAPY AND ONCOLOGY, 194:S2308–S2311. doi:10.1016/s0167-8140(24)00952-6.
- Vancouver
- 1.Verghote F, Dirix P, Van Praet C, Berghen C, Vanneste B, Junius S, et al. Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434). In: RADIOTHERAPY AND ONCOLOGY. 2024. p. S2308–11.
- IEEE
- [1]F. Verghote et al., “Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434),” in RADIOTHERAPY AND ONCOLOGY, Glasgow, UK, 2024, vol. 194, no. Supplement 1, pp. S2308–S2311.
@inproceedings{01J8FZK1NWZ8S9KP0PKJNA7X7T,
articleno = {{277}},
author = {{Verghote, Flor and Dirix, Piet and Van Praet, Charles and Berghen, Charlien and Vanneste, Ben and Junius, Sara and Liefhooghe, Nick and Noé, Leen and De Meerleer, Gert and Ost, Piet and Fonteyne, Valerie}},
booktitle = {{RADIOTHERAPY AND ONCOLOGY}},
issn = {{0167-8140}},
language = {{eng}},
location = {{Glasgow, UK}},
number = {{Supplement 1}},
pages = {{277:S2308--277:S2311}},
title = {{Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)}},
url = {{http://doi.org/10.1016/s0167-8140(24)00952-6}},
volume = {{194}},
year = {{2024}},
}
- Altmetric
- View in Altmetric